Solarvest BioEnergy Inc.

Solarvest BioEnergy Inc.

June 19, 2013 17:33 ET

Solarvest Announces US Patent Application: Organic Omega 3 Algal Products

CHARLOTTETOWN, PRINCE EDWARD ISLAND--(Marketwired - June 19, 2013) - SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest") announces that it has filed a patent to protect its unique process for the algal-based production of a line of highly purified Omega 3 products. This patent pending process will allow Solarvest to be in complete compliance with both EU and USDA organic regulations. In addition to being environmentally unsustainable, current Omega 3 production based on wild capture fisheries and processes can not make this organic claim.

The Omega 3 nutraceutical and food enhancement market has grown substantially since early in the 2000's. The total market, in all forms, including human and animal health is reported to be 13 billion dollars globally and forecasted to be approximately 7 billion in the United States by 2015. The health benefits of marine based Omega 3 fatty acids including coronary heart disease prevention has been generally recognized and has led to these substantial consumption levels.

Vegetarian, vegan and organic diets tend to be low in Omega 3s. Solarvest intends to meet this market need with a premium organic Omega 3 product line which, for the first time, will provide the opportunity for food processors to enhance and consumers to supplement, their respective products and diets.

About Solarvest BioEnergy:

Solarvest BioEnergy Inc. is an algae technology company whose algal-based production platform provides it with an extremely flexible system capable of being adapted to produce clean energy in the form of hydrogen and health products such as Omega oils in an economic and environmentally sensitive manner.

The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from Solarvest's expectations and projections.

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information